Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes. - Wikidata - awgldk - TriplyDB

Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes.

Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes.

http://www.wikidata.org/entity/Q40640901

about

Improved systemic delivery of oncolytic reovirus to established tumors using preconditioning with cyclophosphamide-mediated Treg modulation and interleukin-2 Induction and modification of anti-TNP reaginic and IgG antibody responses by reactive trinitrophenyl derivatives Phenotype, functions and fate of adoptively transferred tumor draining lymphocytes activated ex vivo in mice with an aggressive weakly immunogenic mammary carcinoma Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs.Induction of suppressor T cells in delayed-type hypersensitivity to Mycobacterium bovis BCG in low-responder mice Tumor-enhancing suppressor activator T cells in spleens and thymuses of tumor immune mice Induction of enhanced resistance against encephalomyocarditis virus infection of mice by nonviable Mycobacterium tuberculosis: mechanisms of protection.Selective effects of cyclophosphamide therapy on activation, proliferation, and differentiation of human B cells.GM-CSF gene-modifed cancer cell immunotherapies: of mice and men.Stimulation of anti-tumor immunity by photodynamic therapy Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus.Autoimmune vasculitis resulting from in vitro immunization of lymphocytes to smooth muscle In situ immune autoradiographic identification of cells in heart tissues of mice with coxsackievirus B3-induced myocarditis.In vivo detection and partial characterization of effector and suppressor cell populations in spleens of mice with large metastatic fibrosarcomas.The effect of adjuvant cyclophosphamide or tamoxifen on the numbers of lymphocytes bearing T cell or NK cell markers "Sneaking through": a T-cell-dependent phenomenon.Combination approaches to potentiate immune response after photodynamic therapy for cancer.Differential cyclophosphamide sensitivity of precursor cells in allogeneic and H-2 restricted cytotoxic responses.Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice.Induction and mode of action of suppressor cells generated against human gamma globulin. II. Effects of colchicine.Cyclophosphamide eliminates suppressor T cells in age-associated central regulation of delayed hypersensitivity in mice.Regression and inhibition of sarcoma growth by interference with a radiosensitive T-cell population.Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.Enhancement of delayed hypersensitivity reaction with varieties of anti-cancer drugs. A common biological phenomenon.Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2.Antiidiotypic immunity in interstitial nephritis. II. Rats developing anti-tubular basement membrane disease fail to make an antiidiotypic regulatory response: the modulatory role of an RT7.1+, OX8- suppressor T cell mechanism.Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases.Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies.Rescue of anti-influenza A virus cytotoxic T-lymphocyte responses in chemotherapy-suppressed mice Immunosuppression with cyclophosphamide favors reinfection with recombinant Toxoplasma gondii strains.Correlation between in vivo and in vitro studies of modulation of resistance to experimental Candida albicans infection by cyclophosphamide in mice Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression.Pharmacologic and chemical adjuvants in tumor virotherapy.Cornea: Window to Ocular Immunology.Autophagy inhibition in cancer therapy: metabolic considerations for antitumor immunity.Immunotherapy of HPV infection-caused genital warts using low dose cyclophosphamide.Down-regulation of cytotoxic T lymphocyte generation by two distinct suppressor-cell systems.T-cell tolerance in transgenic mice expressing major histocompatibility class I molecules in defined tissues.The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy.

P2860

Q24612603-7B5538C3-1A70-48C3-9FFE-6339DADC4A50 Q28324536-952D368A-C1E1-4A71-9A04-F8084AA7D2FA Q33738279-E03E4F0D-0C27-49CD-81C2-E1140AA2067C Q33896713-5610C26F-9693-4AEA-A2AC-742AA118A033 Q33902397-49F1FB54-A7D1-48A4-8838-EB0043549E86 Q34038870-83A27D16-81F0-4B9B-B570-54EBCF774E33 Q34462481-36797CAB-36B9-4EA4-9415-43E08DF624F5 Q34566881-3E49104D-B66B-4C76-A8F5-EA3ED1D7D2A9 Q34591128-C3A4C9B1-4F42-457D-9BBF-50BE1AC52190 Q34697795-EF75483F-C96F-4CDA-A85C-6B310AC1F1AD Q35238258-90246894-125B-432F-9938-8D267EFEBBEF Q35835377-1FABD5AB-518F-4692-8FCD-300153C2169D Q35856321-BE9AE571-FA05-4F08-BEBF-B5F21BF41BD3 Q35992368-4C5F7D84-47B5-41E7-8252-A9CA43BE7B08 Q36027452-B646AB3C-9943-4B81-AB41-A69E1C960B38 Q36045731-065AC5BC-1C60-41EE-99A0-BBC7F5D60EFB Q36253709-04D0D7DB-77CB-4674-946F-904C0EB5714B Q36341051-E91F0F84-1153-4E15-B978-BE147DF48517 Q36341321-7FA3799F-FF76-4B60-8872-36D182661CD7 Q36341441-C9822A4E-6736-4C8E-8408-2829F4CA7F1B Q36341471-7BCFE7E5-ED23-407A-B189-F070C0EEB56F Q36341857-5EF583AF-99A1-4487-8D2D-3632A216C5D5 Q36344775-15863EE8-5365-4C8B-A38E-7C0A04A102FE Q36345351-8C78E5CD-11D6-4E56-9A35-D9192BF89A1A Q36346300-D5C24559-DA60-4DDB-ACCB-33D4C0283E28 Q36348452-3703A03A-FEEB-4138-BB40-8C4D4DFF1934 Q36348613-5B0924EE-2F26-41D1-8EC4-50BE631C448E Q36432030-E7F28548-569C-47D8-90B2-B8EA8F555C4C Q36821113-DB24E324-789D-4CDE-A5A8-8E334CAB70F4 Q36892330-B00D9186-4623-475A-8D8D-0AF9B078ADB2 Q36899227-65C22EA6-5C56-4A8C-BABD-C119D796446C Q37110457-8306D1AC-26C8-4F1C-97C7-D0B0954D930C Q37270469-B2D27232-5C56-46FC-A004-B8BB6B73CE75 Q37492540-892C15AA-6A82-4F0F-8619-307CDC88CA0B Q37905546-FC216FF1-AD65-4AC0-8348-8AE1D90659A3 Q38034270-F03B3BC7-57EB-4CF0-9CC3-89C74B56F7FE Q38211240-8A3A3257-AE33-4647-B4CF-16E848E1437F Q38518755-FB61F169-B70B-4C63-9764-9AF7BDB8A6C6 Q38606069-C3B9E6E9-B726-42DB-B145-C676EA0B31C5 Q38959130-E5E88309-DD09-4C9A-B63F-D1F9CE0FD6D7

P2860

Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes.

http://www.wikidata.org/entity/Q40640901

description

1977 nî lūn-bûn

@nan

1977年の論文

@ja

1977年論文

@yue

1977年論文

@zh-hant

1977年論文

@zh-hk

1977年論文

@zh-mo

1977年論文

@zh-tw

1977年论文

@wuu

1977年论文

@zh

1977年论文

@zh-cn

name

Cyclophosphamide-sensitive T l ...... cific cytotoxic T lymphocytes.

@en

type

label

Cyclophosphamide-sensitive T l ...... cific cytotoxic T lymphocytes.

@en

prefLabel

Cyclophosphamide-sensitive T l ...... cific cytotoxic T lymphocytes.

@en

P1433

Q40640901-036B2722-A73E-458B-A6B5-63DD77D8274A

P1476

Q40640901-743F6271-8A50-4241-B015-D25EAC96AE9A

P2093

Q40640901-2F45ED4C-8665-4BE0-B031-25F166102453

Q40640901-686E7161-18AD-424F-89FB-D86182DC2D81

Q40640901-9DF79C5B-998E-4A96-8AB2-9CC65E754E34

Q40640901-DB3F0865-ACEC-40DA-9E76-FA4635514BA3

P2860

Q40640901-16F2F03E-EBE0-4DD5-8188-260AED8B0AEA

Q40640901-22D48B2F-79F9-4CC0-B1CD-FFFFBCBAF4BF

Q40640901-78879ECC-5F1C-4FCB-A3AA-57A20C68BC8E

Q40640901-8CFE70D9-2140-49D3-8F82-CDAC734D023D

Q40640901-9A5D8DC1-5147-49DD-82F5-83F77D8ADB8B

Q40640901-BC5AAE96-15B3-4DFA-B1FA-2B426CEA1713

Q40640901-BCE75AE1-DFD7-4831-9C9D-A2F8DCC3E7FD

Q40640901-C219B41A-1BFF-4AF1-9A0E-72CA37AAB2AC

Q40640901-F49F127B-B933-4A73-9B36-7009DA038CD6

Q40640901-F92A073E-58E2-4925-A33A-D9D797898103

P304

Q40640901-0E004421-421D-4677-93E2-409AFA886327

P31

Q40640901-BC9844A7-F98E-458D-9B46-B440B26978A2

P356

Q40640901-67BF1953-0DA5-48FB-9216-19D3920164DA

P407

Q40640901-7AFF8FD7-FC2A-4056-B0C0-C491B33DA8A0

P433

Q40640901-61BF2201-C5F6-463E-9C34-125F6AB87750

P478

Q40640901-301425EE-1561-45AA-B256-CB2EA27E43CC

P577

Q40640901-CB378AFC-1CA7-4331-92C2-E299C3EC592F

P5875

Q40640901-75AAB3D7-E1BA-468C-A9B4-076F5D774C8E

P698

Q40640901-BCD0FFA0-EB41-4781-8E05-CBAEF1061C5B

P921

Q40640901-3F85A014-7458-48E2-A1B4-1F10C532B99E

P932

Q40640901-39410F3E-B4A0-4E39-9061-614123648E99

P356

P1433

Journal of Experimental Medicine

P1476

Cyclophosphamide-sensitive T l ...... cific cytotoxic T lymphocytes.

@en

P2093

Pfizenmaier K

http://www.w3.org/2001/XMLSchema#string

Röllinghoff M

http://www.w3.org/2001/XMLSchema#string

Starzinski-Powitz A

http://www.w3.org/2001/XMLSchema#string

Wagner H

http://www.w3.org/2001/XMLSchema#string

P2860

Role of major histocompatibility complex gene products in delayed-type hypersensitivity.

Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide.

Genetic control of specific immune suppression. IV. Responsiveness to the random copolymer L-glutamic acid50-L-tyrosine50 induced in BALB/c mice by cyclophosphamide.

Are contact hypersensitivity cells cytotoxic?

A rapid method for the isolation of functional thymus-derived murine lymphocytes

T cell proliferation in the mixed lymphocyte culture does not necessarily result in the generation of cytotoxic T effector cells.

Cell-mediated cytotoxicity, allograft rejection, and tumor immunity.

T-cell-mediated immune responses induced in vitro: a probe for allograft and tumor immunity.

Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.

Virus and trinitrophenol hapten-specific T-cell-mediated cytotoxicity against H-2 incompatible target cells.

P304

455-459

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.145.2.455

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

145

http://www.w3.org/2001/XMLSchema#string

P577

1977-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277373586

http://www.w3.org/2001/XMLSchema#string

P698

299883

http://www.w3.org/2001/XMLSchema#string

P921

P932

2180611

http://www.w3.org/2001/XMLSchema#string